KORSANA BIOSCIENCES INC
KRSANASDAQ๐ #3570 by market capUS Equity
โโ
Quote unavailableTrack KRSA
Get earnings, price moves & breaking news on Telegram
24hโ
7dโ
14dโ
30dโ
ytdโ
1yโ
๐ฆMarket Cap
$176M
Small Cap
๐Revenue Growth (YoY)
3.7%
Slowing
๐Gross Margin
25.6%
Moderate
๐ตFCF Margin
-5006.1%
Thin
โ๏ธP/S Ratio
171.5x
Expensive
Otter Score
โ
Insufficient data
No chart data available for KRSA.
Trading Snapshot
- Day Range
- โ
- 52-Week Range
- $7.19 โ $59.36
- Volume (shares)
- โ
- Avg Volume (shares)
- โ
- Shares Outstanding
- 4.7M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- $2M
- Last Q Revenue
- โ
- P/E Ratio
- -0.1
- P/S Ratio
- 171.5x
- EPS (TTM)
- $-385.61
- Dividend Yield
- 0.00%
KORSANA BIOSCIENCES INC
KRSAFinancial Trends
Financial history unavailable.
About KORSANA BIOSCIENCES INC
Cyclerion Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the discovery, development, and commercialization of human therapeutics. Its product pipeline includes several sGC stimulators, small molecules that act synergistically with nitric oxide on sGC to boost production of cyclic guanosine monophosphate. The company was founded on September 6, 2018 and is headquartered in Cambridge, MA.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
๐Qualityโ
โ
โ
โ
โ
๐Growthโ
โ
โ
โ
โ
โ๏ธValuationโ
โ
โ
โ
โ
โกMomentumโ
โ
โ
โ
โ
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.